Oscar Health Stock Rises Following Raised 2026 Guidance and Wall Street Price Target Hikes

Oscar Health Inc. (NYSE: OSCR) shares rose 2.38% to $33.11 following positive updates from analysts after the company's 2026 Investor Day. Barclays raised its price target to $49, while Baird and Stephens & Co. increased their targets to $33 and $34, respectively. The company also upgraded its 2026 earnings guidance by $100 million to a range of $600 million to $800 million and improved its Medical Loss Ratio expectation to 81.0%-82.0%. Oscar reaffirmed its total revenue guidance for 2026 at $18.7 billion to $19.0 billion.